Key Takeaways
- Eli Lilly sued Indianapolis-based Premier Weight Loss for selling repackaged and redosed versions of its Mounjaro and Zepbound.
- Lilly said the weight loss clinic could gain $1,000 a month in profits from charging patients for manipulated products.
- PWL said its products are safer than compounded tirzepatide, but Lilly argued their lack of sterility and inadequate instructions for use pose a safety risk.
Eli Lilly opened a new front in its clash with weight loss companies seeking to profit from the demand for obesity drugs by filing a...
The complaint, filed in US District Court for the Southern District of Indiana on 7 April, accuses Premier Weight Loss of trademark infringement, false designation...